GSCs dissociated from tumor spheres were starved from mitogens and then treated with agonist LY 379268 (100 nM), which inhibited forskolin-stimulated cyclic adenosine monophosphate (cAMP) formation and increased p-Erk1/2 and p-Akt/PKB levels. Here, AKT1 is linked to neoplasm.